BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 17390054)

  • 1. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving epidemiology of malignancies in HIV.
    Bonnet F; Chêne G
    Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches to AIDS-related malignancies.
    Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
    Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS-related malignancies: revisited.
    Cáceres W; Cruz-Amy M; Díaz-Meléndez V
    P R Health Sci J; 2010 Mar; 29(1):70-5. PubMed ID: 20222338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urological management of the patient with acquired immunodeficiency syndrome.
    Heyns CF; Fisher M
    BJU Int; 2005 Apr; 95(5):709-16. PubMed ID: 15784082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related lung cancer -- a growing concern?
    Powles T; Nelson M; Bower M
    Int J STD AIDS; 2003 Oct; 14(10):647-51. PubMed ID: 14596765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growing problem of non-AIDS-defining malignancies in HIV.
    Pantanowitz L; Schlecht HP; Dezube BJ
    Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies in HIV: the Indian scenario.
    Dhir AA; Sawant SP
    Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
    J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-associated cancers: an emerging challenge.
    Phatak UA; Joshi R; Badakh DK; Gosavi VS; Phatak JU; Jagdale RV
    J Assoc Physicians India; 2010 Mar; 58():159-62. PubMed ID: 20848813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre.
    Kiely B; O'Flaherty J; Surah S; Kieran J; O'Donnell D; Bergin C; Mulcahy F
    Int J STD AIDS; 2010 May; 21(5):332-6. PubMed ID: 20498102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
    Grulich AE
    Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.